Mielko, J.; Rawicz-Pruszyński, K.; Sędłak, K.; Gęca, K.; Kwietniewska, M.; Polkowski, W.P.
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes. Cancers 2020, 12, 2387.
https://doi.org/10.3390/cancers12092387
AMA Style
Mielko J, Rawicz-Pruszyński K, Sędłak K, Gęca K, Kwietniewska M, Polkowski WP.
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes. Cancers. 2020; 12(9):2387.
https://doi.org/10.3390/cancers12092387
Chicago/Turabian Style
Mielko, Jerzy, Karol Rawicz-Pruszyński, Katarzyna Sędłak, Katarzyna Gęca, Magdalena Kwietniewska, and Wojciech P. Polkowski.
2020. "Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes" Cancers 12, no. 9: 2387.
https://doi.org/10.3390/cancers12092387
APA Style
Mielko, J., Rawicz-Pruszyński, K., Sędłak, K., Gęca, K., Kwietniewska, M., & Polkowski, W. P.
(2020). Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes. Cancers, 12(9), 2387.
https://doi.org/10.3390/cancers12092387